Select Page

FabRx: The First Clinical Study Using Personalized 3D Printed Pills (In Humans)

FabRx: The First Clinical Study Using Personalized 3D Printed Pills (In Humans)

Written by David

September 11, 2019

[post-views]

3D printing technology is becoming disruptive to the pharmaceutical industry. The manufacturing of personalized medicine, such as patient-specific pills, can make customized drug delivery and dosing change the way people take their medicines forever. Still, the manufacturing technology appears to be at an early stage, with a lot of research but few outcomes.

 .

The first 3D printed prescription drug was finally commercially available in 2016, officially approved by the FDA and released to the US market. But up to now, there were no 3D printers on the market adapted for printing personalized medicines, until pharma-tech pioneering experts, FabRx, successfully completed the world’s first-in-human clinical study using their proprietary Printlets technology which relies on personalized 3D printed dosage forms to treat children with a rare metabolic disease.

 .

The study demonstrates for the first time that 3D printing offers a feasible, rapid and automated approach to prepare oral tailored-dose therapies […]

You May Also Like…

Pin It on Pinterest

Share This

Share this post with your friends!

Shares